Damora Therapeutics (DMRA) Long-Term Investments (2021 - 2023)

Damora Therapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $4.0 million for Q1 2023.

• Quarterly Long-Term Investments fell 51.42% year-over-year to $4.0 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $4.0 million (down 51.42% YoY) and the FY2022 annual result came in at $5.8 million, down 35.54% from the prior year.
• Long-Term Investments was $4.0 million for Q1 2023 at Damora Therapeutics, down from $5.8 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $38.6 million in Q1 2021 and bottomed at $4.0 million in Q1 2023.
• A 3-year average of $15.6 million and a median of $8.2 million in 2022 frame the typical range for Long-Term Investments.
• Peak annual rise in Long-Term Investments reached 35.54% in 2022, while the deepest fall reached 80.79% in 2022.
• Damora Therapeutics' Long-Term Investments stood at $9.0 million in 2021, then tumbled by 35.54% to $5.8 million in 2022, then tumbled by 32.03% to $4.0 million in 2023.
• Business Quant data shows DMRA's Long-Term Investments at $4.0 million in Q1 2023, $5.8 million in Q4 2022, and $6.8 million in Q3 2022.